Our Putnam PHMR colleagues delivered an in-depth analysis on the burden of patient hospitalizations in France as a result of COVID-19. The study population consisted of all patients hospitalized in 2020 – assessing healthcare resource consumption in the hospital setting through the French national health insurance claims database. The article is featured in the Journal of Market Access & Health Policy.
In an increasingly complex and rapidly evolving healthcare environment, pharma leaders need to up their go-to-market (GTM) game to capture the value of pharmaceutical innovation. With the industry expected to add $450bn in revenue by 2028 (nearly 70% from new therapies), the stakes to get launches right have never been higher.
In this whitepaper we review the current state of solid tumor cell therapies and assess emerging approaches for expanding the target space with optimal antigens, combating resistance through multi-antigen targeting, and improving antigen recognition and signaling.
Putnam, a leader in strategy consulting for life sciences, announces its January 2023 promotions – with Joanna Rys to Partner! The firm continues to grow and expand – and these colleagues have been an important part in the firm’s journey, especially throughout the last year.
Alex Busch, Ph.D., Partner and Scott Briggs, Principal were featured in BioCentury on the Inflation Reduction Act. They share their knowledge and expertise on strategically navigating the Act and what we might expect to see.
Vault Firsthand recently released their internship rankings by industry for 2023 based on the results of the 2022 internship survey. We are thrilled that Putnam is ranked #1 for the best consulting internship program!
The drug development pipeline has evolved from primary care to specialty and now advances deeper into exquisitely targeted therapies for shrinking niches of addressable populations. In parallel, governments and private payers continue to struggle with appropriately rewarding innovation while managing healthcare budgets in the face of aging populations.
Last week, Putnam came together as one collaborative team with colleagues from around the world to participate in their annual LEAD training – a few days of leadership development, networking, team building, in-depth workshops, and more.
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.
